Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns 
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
OpenAI Restricts Astra AI Over Cyberattack Risks 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
The current state of the medical cannabis and cannabinoids use…
Achievements, Priorities, Trends, and Barriers
Toronto, Ontario, Feb. 26, 2018 -- The International Pharmaceutical Academy is pleased to announce its third upcoming Medicinal Cannabis Conference being held in Toronto, Canada at DoubleTree by Hilton Toronto Downtown on March 23 - 24, 2018.
This two-day conference will feature 10 of the world renowned experts from across North America including; Dr. Steven Laviolette from Schulich School of Medicine, Dr. Jahan Marcu from Americans for Safe Access Patient Focused Certification program, Dr. Philippe Lucas from The Canadian Medical Cannabis Council, Dr. Mark Lewis from NaPro Research, USA, Dr. Youbin Zheng, University of Guelph, and many more.
This conference will bring together a diverse range of professionals from wide range of research and development, medical, and cannabis industry experts who are directly involved; in Innovations in Cultivation, Processing, Cannabis Extraction, and Product Development of high quality and safe cannabis.
Among other topics, this event will create a forum to share results from ongoing efforts in understanding the use of cannabis (marijuana) for medical purposes in patients, cannabis substitution for opioids, alcohol, tobacco and other substances, and the current position by medical organizations on medical marijuana.
More information about the conference, including registration details, is
available at: http://www.ipacanada.com/CMH2018/index.html
Source: International Pharmaceutical Academy (IPA)
For further information: Media Contact: Rebecca Tan, Communications Co-ordinator, Direct line: (416) 410-7402, Fax: 1-888-236-5480, [email protected]
